Robbins, Peter A.

Natural selection on EPAS1 ( HIF2α ) associated with low hemoglobin concentration in Tibetan highlanders

Beall, C. M., Cavalleri, G. L., Deng, L., Elston, R. C., Gao, Y., Knight, J., Li, C., Li, J. C., Liang, Y., McCormack, M., et al. (2010) · Proceedings of the National Academy of Sciences

High Altitude and HypoxiaGenetics and Physical Performance

Cited by 845

Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function

Lakhal-Littleton, S., Wolna, M., Carr, C. A., Miller, J. J. J., Christian, H. C., Ball, V., Santos, A., Diaz, R., Biggs, D., Stillion, R., et al. (2015) · Proceedings of the National Academy of Sciences

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 234

An essential cell-autonomous role for hepcidin in cardiac iron homeostasis

Lakhal-Littleton, S., Wolna, M., Chung, Y. J., Christian, H. C., Heather, L. C., Brescia, M., Ball, V., Diaz, R., Santos, A., Biggs, D., et al. (2016) · eLife

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 184

Mutation of von Hippel–Lindau Tumour Suppressor and Human Cardiopulmonary Physiology

Smith, T. G., Brooks, J. T., Balanos, G. M., Lappin, T. R., Layton, D. M., Leedham, D. L., Liu, C., Maxwell, P. H., McMullin, M. F., McNamara, C. J., et al. (2006) · PLoS Medicine

High Altitude and HypoxiaPulmonary Hypertension Research and Treatments

Cited by 182

Regulation of growth differentiation factor 15 expression by intracellular iron

Lakhal, S., Talbot, N. P., Crosby, A., Stoepker, C., Townsend, A. R. M., Robbins, P. A., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2009) · Blood

GDF15 and Related BiomarkersIron Metabolism and Disorders

Cited by 95

Regulation of hepcidin expression at high altitude

Talbot, N. P., Lakhal, S., Smith, T. G., Privat, C., Nickol, A. H., Rivera-Ch, M., León-Velarde, F., Dorrington, K. L., Mole, D. R., & Robbins, P. A. (2012) · Blood

Iron Metabolism and DisordersHigh Altitude and Hypoxia

Cited by 93

Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation

Formenti, F., Beer, P. A., Croft, Q. P. P., Dorrington, K. L., Gale, D. P., Lappin, T. R. J., Lucas, G. S., Maher, E. R., Maxwell, P. H., McMullin, M. F., et al. (2011) · The FASEB Journal

Cancer, Hypoxia, and MetabolismPulmonary Hypertension Research and Treatments

Cited by 92

Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control

Cheng, X., Prange-Barczynska, M., Fielding, J. W., Zhang, M., Burrell, A. L., Lima, J. D. C. C., Eckardt, L., Argles, I. L. A., Pugh, C. W., Buckler, K. J., et al. (2020) · Journal of Clinical Investigation

Neuroscience of respiration and sleepCancer, Hypoxia, and Metabolism

Cited by 62

Fetal liver hepcidin secures iron stores in utero

Kämmerer, L., Mohammad, G., Wolna, M., Robbins, P. A., & Lakhal-Littleton, S. (2020) · Blood

Iron Metabolism and DisordersTrace Elements in Health

Cited by 38

Induced Disruption of the Iron-Regulatory Hormone Hepcidin Inhibits Acute Inflammatory Hypoferraemia

Armitage, A. E., Lim, P. J., Frost, J. N., Pasricha, S.-R., Soilleux, E. J., Evans, E., Morovat, A., Santos, A., Diaz, R., Biggs, D., et al. (2016) · Journal of Innate Immunity

Iron Metabolism and DisordersImmune Response and Inflammation

Cited by 20